Compare CDW Corp. (CDW) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CDW Corp. vs Novavax Inc — how do they compare? CDW Corp. trades at $135.37 (market cap $16.92B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: CDW Corp. is far larger — about 12.9× Novavax Inc's market cap, and CDW Corp. pays a 1.86% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| CDW | NVAX | |
|---|---|---|
Market Cap | $16.92B | $1.31B |
Sector | Technology | Health |
52-Week High | $170.77 | $11.19 |
52-Week Low | $99.30 | $6.22 |
Enterprise Value | $22.52B | $889.30M |
Dividend Yield | 1.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CDW Corp.
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
